BioCardia-Final-Logo-2016-JPEG.jpg
BioCardia Reports Second Quarter 2020 Financial Results and Business Highlights
August 13, 2020 07:00 ET | BioCardia, Inc.
SAN CARLOS, Calif., Aug. 13, 2020 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today...
BioCardia-Final-Logo-2016-JPEG.jpg
BioCardia To Conduct Mid-Year Conference Call and Corporate Update August 13, 2020
August 07, 2020 08:00 ET | BioCardia, Inc.
SAN CARLOS, Calif., Aug. 07, 2020 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today...
Madrigal logo.jpg
Madrigal Pharmaceuticals Reports 2020 Second Quarter Financial Results and Highlights
August 06, 2020 06:50 ET | Madrigal Pharmaceuticals, Inc.
CONSHOHOCKEN, Pa., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) today announced its second quarter 2020 financial results and highlights: “The Madrigal team and...
QMI-Logo-Long-1000px.jpg
Cardiovascular And Soft Tissue Repair Patch Market To Reach USD 7,610.5 Billion By 2028
July 20, 2020 05:05 ET | Quince Market Insights
Pune, India, July 20, 2020 (GLOBE NEWSWIRE) -- The global Cardiovascular and Soft Tissue Repair Patch Market is forecast to reach USD 7,610.5 billion by 2028, growing at a CAGR of 9.3% over the...
SARS-CoV-2 Cell Entry Mechanisms in Intact Human Heart Published in JACC: Basic to Translational Science by University of Colorado Anschutz Medical Campus and ARCA biopharma Investigators
July 07, 2020 08:30 ET | ARCA biopharma, Inc.
Integrin A5 may be a new target for intervening in the cell infectious processFindings may lead to the development of precision therapeutic approaches to prevent SARS-CoV-2-cell entry while preserving...
Marius_logo_CMYK.jpg
Marius Pharmaceuticals Announces Issuance of Two Key Patents Protecting its Proprietary Oral Testosterone Therapy
May 21, 2020 06:30 ET | Shah Capital
RALEIGH, N.C., May 21, 2020 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals announced today that the United States Patent and Trademark Office (USPTO) has issued two key patents related to its lead...
Daniel R. Goldstein, MD, Named Incoming Editor-in-Chief of the Journal of Heart and Lung Transplantation ADDISON, Texas, May 12, 2020 (GLOBE NEWSWIRE) -- The International Society for Heart and Transplantation, which publishes the Journal of Heart and Lung Transplantation, named Daniel R. Goldstein,...
Clinical Data Evaluating Gencaro for the Treatment of Atrial Fibrillation in Heart Failure Patients Featured in Three Presentations at the 2020 Heart Rhythm Scientific Sessions
May 07, 2020 08:30 ET | ARCA biopharma, Inc.
New data provide additional evidence of efficacy for Gencaro compared to active control in a pharmacogenetically-defined HF population at risk for AF recurrence °  26% reduction in total time spent...
Life Extension launches NitroVasc Boost on-the-go berry-flavored powder for circulatory support
March 19, 2020 10:00 ET | Life Extension
Fort Lauderdale, Fla., March 19, 2020 (GLOBE NEWSWIRE) -- Promoting heart health and blood flow has never been more convenient—or delicious. Life Extension® today announced the launch of NitroVasc™...
ARCA biopharma Announces Fiscal Year 2019 Financial Results and Provides Corporate Update
February 18, 2020 16:30 ET | ARCA biopharma, Inc.
U.S. FDA Special Protocol Assessment agreement for a single pivotal Phase 3 clinical trial (PRECISION-AF) of genetically-targeted GencaroPRECISION-AF clinical trial initiation anticipated fourth...